- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Equine CA199 antibody and antigen (recombinant protein)
Diagnostic anti-Equine CA199 antibodies pairs and antigen for animal health (animal Equine/Horse pancreatic and biliary tract tumors) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Equine disease testing products collection >>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-EQU-CA199-Ag01 | Equine CA199 | $3090.00 |
| GMP-EQU-CA199-Ab01 | Anti-Equine CA199 mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-CA199-Ab02 | Anti-Equine CA199 mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-CA199-Ab03 | Anti-Equine CA199 human monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-CA199-Ab04 | Anti-Equine CA199 human monoclonal antibody (mAb) | $3090.00 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. | GMP-EQU-CA199-Ag01 |
| Product Name | Equine CA199 |
| Target/Biomarker | Equine CA199 |
| Expression platform | E.coli |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Anti-Equine CA199 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA199 level test of animal Equine/Horse with pancreatic and biliary tract tumors. |
| Tag | His | Reconized/Reactive Specics | Equine CA199 |
| Product description | Recombinant Equine CA199 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-EQU-CA199-Ab01,GMP-EQU-CA199-Ab02 |
| Target/Biomarker | Equine CA199 |
| Product Name | Anti-Equine CA199 mouse monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Recombinant Equine CA199 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA199 antibodies in Equine CA199 level test of animal Equine/Horse with pancreatic and biliary tract tumors. |
| Product description | Anti-Equine CA199 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA199 antibodies. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-EQU-CA199-Ab03,GMP-EQU-CA199-Ab04 |
| Target/Biomarker | Equine CA199 |
| Product Name | Anti-Equine CA199 human monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Recombinant Equine CA199 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA199 antibodies in Equine CA199 level test of animal Equine/Horse with pancreatic and biliary tract tumors. |
| Product description | Anti-Equine CA199 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Cancer Antigen 199 (CA199) is a glycoprotein biomarker with vital implications in equine health, particularly in the sphere of cancer diagnosis and monitoring. This biomarker is associated with several types of cancer in horses, including those affecting the gastrointestinal tract and pancreas. Structurally, CA199 is classified as a carbohydrate antigen, featuring a protein core with attached carbohydrate molecules.
In the context of equine health, CA199 assumes significance as a diagnostic tool for the early detection of cancer. Cancers affecting the gastrointestinal and pancreatic regions can be insidious, often presenting with subtle or nonspecific clinical signs. CA199 blood tests offer a non-invasive and highly sensitive means of identifying these malignancies, enabling prompt intervention and potentially improving treatment outcomes.
CA199 levels in a horse's bloodstream become elevated when cancer cells, particularly those found in the gastrointestinal and pancreatic cancers, produce and release this glycoprotein. As a result, CA199 serves as a biomarker that can be readily detected and quantified through blood tests.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
